Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brain Stimulation to Improvement After Cerebellar Damage

NCT: NCT07838961 · NOT_YET_RECRUITING

NCT IDNCT07838961
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2028-12
SponsorGeorge Wittenberg (OTHER)
First posted
Last updated

Brief Summary

The work will examine the mechanisms and potential therapeutic effects of transcranial magnetic stimulation on upper-limb sensorimotor function in individuals with cerebellar dysfunction, including those with damage due to stroke or autoimmune disease. The study team will work toward a goal of non-invasive stimulation-based neuromodulatory interventions for cerebellar disorders using a closely integrated, clinically oriented cross-species approach. There will be a related study in nonhuman primates.

Frequently Asked Questions

What is Brain Stimulation to Improvement After Cerebellar Damage?

Brain Stimulation to Improvement After Cerebellar Damage is a clinical trial registered under NCT07838961. Current status: NOT_YET_RECRUITING.

What is the status of NCT07838961?

The current status of NCT07838961 (Brain Stimulation to Improvement After Cerebellar Damage) is: NOT_YET_RECRUITING.

When did Brain Stimulation to Improvement After Cerebellar Damage start?

Brain Stimulation to Improvement After Cerebellar Damage started on 2026-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑